共 9 条
- [1] Lynn WA.Anti-endotoxin therapeutic options for the treatment ofsepsis. Journal of Antimicrobial Chemotherapy . 1998
- [2] Shenep JL,Mogan KA.Kinetics of endotoxin release during antibiotic therapy for experimental gram negative bacterial sepsis. The Journal of Infectious Diseases . 1984
- [3] O’Riordain MG,O’riordain Ds,Molloy RG,et al.Dosage andtiming of anti-TNF antibody treatment determine its effect on resistance to sepsis after injury. Journal of Surgical Research . 1996
- [4] Weiss J,Franson RC,Beckerdite S,et al.Partial characterizationand purification of a rabbit granulocyte factor that increase permeability of Escherichia coli. The Journal of Clinical Investigation . 1975
- [5] Marra MN,Wilde CG,Griffith JE,et al.Bactericidal/permeability-increasing protein has endotoxi n-neutralizing activity. JImmunol . 1990
- [6] Fisher CJ,Marra MN,Pllardy JE,et al.Human neutrophil bactericidal /permeability-increasing protein red uces mortality ratefrom endotoxin challenge: a placebo-controlled study. Critical Care Medicine . 1994
- [7] Mayeux PR.Pathobiology of lipopolysaccharide. Journal of Ecotoxicology and Environmental Monitoring . 1997
- [8] Jiang JX,Bahrami S,Leichtfried G,et al.Kinetics of endotoxinand TNF appearance in portal and systemic circulation after hemorrhagic shock. Annals of Surgery . 1995
- [9] Van Dervort AL,Danner RL.Antiendotoxin approaches to septicshock therapy. Critical Care Medicine . 1994